newsfilter
← Latest News
Business Wire·

Cellistic and Celyad Oncology Announce GMP Cell Therapy Manufacturing Operations Transaction

Cellistic, the cell therapy development and manufacturing business of Ncardia BV, and Celyad Oncology ((Euronext &, NASDAQ:CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T)